4//SEC Filing
BRANDICOURT OLIVIER 4
Accession 0001508518-26-000002
CIK 0001649094other
Filed
Jan 15, 7:00 PM ET
Accepted
Jan 16, 5:08 PM ET
Size
7.4 KB
Accession
0001508518-26-000002
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
BRANDICOURT OLIVIER
Director
Transactions
- Award
Common Stock
[F1]2026-01-15+1,357→ 2,505 total - Award
Stock Option (right to buy)
[F2]2026-01-15+6,750→ 6,750 totalExercise: $48.04Exp: 2035-06-12→ Common Stock (6,750 underlying)
Footnotes (2)
- [F1]Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 12, 2026 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.
- [F2]The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 12, 2026 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.
Signature
Olivier Brandicourt, by /s/ Peter N. Efremenko, Attorney-In-Fact|2026-01-16
Documents
Issuer
Vaxcyte, Inc.
CIK 0001649094
Entity typeother
Related Parties
1- filerCIK 0001508518
Filing Metadata
- Form type
- 4
- Filed
- Jan 15, 7:00 PM ET
- Accepted
- Jan 16, 5:08 PM ET
- Size
- 7.4 KB